🔗 Share this article

A shadow market for unlicensed weight-loss medications is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Drug Acquiring Traction Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to message these accounts privately for supplier links, while also obtaining discount codes.

Active Commerce on Social Networks

Separately, a flourishing trade exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and claims of next-day British shipping. Vendors market the drug there before directing customers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Worries

Nevertheless, physicians and pharmacists have cautions that the distribution of what remains an unapproved medication in the UK is worrisome and could lead to users injecting substances of uncertain source.

Several experts said the demand for retatrutide could be connected to the rising price of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to penalties, prosecution or imprisonment.

Service Reaction and Material Elimination

Based on TikTok, the service has removed problematic content and banned associated keywords and search suggestions. The company stated it was committed to keeping the platform secure and allocating resources in enhancing compliance measures.

Digital Trading Activities

Investigations also discovered groups with up to nine thousand participants marketing the experimental drug using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately brings up channels with numerous of members, populated with photos of weight loss, positive testimonials and step-by-step instructions for preparing or injecting at home.

After minutes of joining one community, a seller posted contact information, where most transactions take place. The vendor provided an instruction manual and guaranteed delivery within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one asked about body mass, medical conditions or previous experience.

Product Information and Costs

Inside these groups, messages show dark colored packages with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When questioned how much time a pen should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram stated it regularly monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering materials they cannot confirm. Although the science behind this drug is valid, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in demand to current price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her staff has already encountered patients harmed by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose users to possibly significant medical dangers”.